Polymorphisms and low plasma activity of Dopamine-beta-hydroxylase in ADHD children

Neuroendocrinology Letters

Volumn 27, Issue 6, 2006, Pages 748-754

  Kopečková, Marta ^a   Paclt, Ivo ^a   Goetz, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

5' ins del; ADHD; C 1021T; C1603T; Dopamine beta hydroxylase; G444A; G910T; Plasma activity; Polymorphism; TaqI

Indexed keywords

ADENINE; CYTOSINE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; GUANINE; NORADRENALIN; SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TAQ POLYMERASE; THYMIDINE;

AMINO ACID SUBSTITUTION; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPAMINE METABOLISM; ENZYME ACTIVITY; ENZYME RELEASE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HERITABILITY; HUMAN; HYPERACTIVITY; IMPULSIVENESS; NUCLEOTIDE SEQUENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPATHETIC NERVE; URINE LEVEL;

EID: 33846442405     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Anderson JS, Williams S, McGee R, Silva PA. DSM-III-R disorders in preadolescent children: Prevalence in a large sample from the general population. Archives of General Psychiatry. 1987; 4: 69-76.
2. Axelrod J, Weinshilboum R. Catecholamines. N Engl J Med. 1972; 287(5): 237-42.
3. Bhaduri N, Sinha S, Chattopadhyay A, Gangopadhyay PK, Singh M, Mukhopadhyay KK. Analysis of polymorphisms in the dopamine Beta hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian Pediatr. 2005; 42(2): 123-9.
4. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991; 148(5): 564-77.
5. Bowden CL, Deutsch CK, Swanson JM. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1988; 27(2): 171-4.
6. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C. et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am-J-Med-Genet-Neuropsychiatr-Genet. 1996; 67(3): 264-288.
7. Comings DE, Gade Andavolu R, Gonzales N, Blake H, Wu S, MacMurray JP. Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention deficit hyperactivity disorder and learning disabilities in Tourette syndrom subjects. Clin. Genet. 1999; 55(3): 160-172.
8. Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet. 1988; 48(1): 48-50.
9. Cubells JF and Zabetian CP. Human genetics of plasma B-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmycology. 2004; 174: 463-476.
10. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F, et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet. 1997;74(4): 374-9.
11. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, et al. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry. 2000; 5(1): 56-63.
12. Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, et al. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet. 1998; 102(5): 533-40.
13. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry. 1999; 4(2): 192-6.
14. Dunnette J, Weinshilboum R. Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am J Hum Genet. 1976; 28(2): 155-66.
15. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, et al. Segregation analysis of attention deficit hyperactivity disorder. Psychiatric Genetics. 1992; 2: 257-275.
16. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11): 1313-23.
17. Freedman LS, Ohuchi T, Goldstein M, Axelrod F, Fish I, Dancis J. Changes in human serum dopamine- -hydroxylase activity with age. Nature. 1972; 236(5345): 310-1.
18. Gabel S, Stadler J, Bjorn J, Shindledecker R, Bowden CL. Biodevelopmental aspects of conduct disorder in boys. Child Psych. Hum. Dev. 1993; 24(2): 125-141.
19. Galvin M, TenEyck R, Shekhar A, Stilwell B, Fineberg N, Laite G, et al. Serum dopamine-beta-hydroxylase and maltreatment in psychiatrically hospitalized boys. Child Abuse and Neglected. 1995; 19(7): 821-832.
20. Galvin M, Stilwell BM, Shekhar R, Kopta SM, Goldfarb SM. Maltreatment, conscience fuctioning and dopamine-beta-hydroxylase in emotionally disturbed boys. Child Abuse and Neglected. 1997; 21(1): 83-92.
21. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry. 2003; 8(3): 299-308.
22. Hess EJ, Rogan PK, Domoto M, Tinker DE, Ladda RL, Ramer JC. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma. Am J Med Genet. 1995; 60(6): 573-9.
23. Hoyle GW, Mercer EH, Palmiter RD, Brinster RL. Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements. J Neurosci. 1994; 14(5): 2455-63.
24. Inkster B, Muglia P, Jain U, Kennedy JL. Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr Genet. 2004; 14(2): 117-20.
25. Ishiguro H, Kim KT, Joh TH, Kim KS. Neuron-specific expression of the human dopamine beta-hydroxylase gene requires both the cAMP-response element and a silencer region. J Biol Chem. 1993; 268(24): 17987-94.
26. Ishii A, Kobayashi K, Kiuchi K, Nagatsu T. Expression of two forms of human dopamine-beta-hydroxylase in COS cells. Neurosci Lett. 1991; 125(1): 25-8.
27. Jensen PS, Martin BA, Cantwell DP. Comorbidity in ADHD: Implications for research, practice and DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry. 1997; 36: 1065-1079.
28. Kim HS, Seo H, Yang C, Brunet JF, Kim KS. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites. J Neurosci. 1998; 18(20): 8247-60.
29. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology. 2002; 27(4): 607-19.
30. Kobayashi K, Kurosawa Y, Fujita K, Nagatsu T. Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res. 1989; 17(3): 1089-102.
31. Koudelová J, Paclt I, Mourek J, Trojan S. Variability in dopamin-betahydroxylase activity in plasma of rats (the effect of age and of hypoxia in plasma of children with mental disorders). In: Van Loun CR, Kvetňanský K, McCarthy R and Axelrod J, editors. Stress: Neurochemical and Humoral Mechanismus. New York: Gordon and Break Science Publishers, S. A; 1989. p. 967-974.
32. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997; 36(6): 737-44.
33. Lewis DA, Hayes TL, Lund JS, Oeth KM. Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research. Neuropsychopharmacology. 1992; 6(2): 127-34.
34. O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, et al. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci. 1994; 86(2): 149-58.
35. O'Connor DT, Levine GL, Frigon RP. Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J Hypertens. 1983; 1(3): 227-33.
36. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J Psychiatr Res. 1986; 20(1): 19-29.
37. Paclt I, Koudelová J. Dopamin-beta-hydroxylase in plasma of psychiatric patients. Activ. nerv. super. 1990; 32(1): 67.
38. Paclt I, Koudelová J. The activity of the dopamine-beta-hydroxylase (DBH) in an experiment in animals in norm and in humans suffering with special developmental dopaminergic disturbance. Proceeding of the IBC International Conference on Dopaminergic Disorders; April 28-29, 1997; Boston, MA, USA.
39. Paclt I, Koudelova J. Changes of dopamine-beta-hydroxylase activity during ontogenesis in healthy subjects and in an experimental model (rats). Physiol Res. 2004; 53(6): 661-7.
40. Quist JS, Kennedy JL. Genetics of Childhood Disorders: XXIII. ADHD, Part 7: The Serotonin System. J Am Acad Child Adolesc Psychiatry. 2001; 40(2): 253-257.
41. Randrup A, Scheel-Kruger J. Diethyldithiocarbamate and amphetamine stereotype behavior. J Pharm Pharmacol. 1966; 18(11): 752.
42. Rogeness GA, Crawford L, McNamara A. Plasma dopamine-beta-hydroxylase and preschool behaviour in children with conduct disorder. Child Psychiatry Hum. De. 1989; 20(2): 149-156.
43. Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR. Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res. 1989; 27(3): 241-251.
44. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet. 2002; 114(2): 154-8.
45. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, et al. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet B Neuropsychiatr Genet. 2003; 119(1): 77-85.
46. Suzuki H, Shimohira M, Iwakawa Y, Nagatsu T. Developmental change of dopamine beta-hydroxylase activity in cerebrospinal fluid of epileptic and non-epileptic children. J Neural Transm Gen Sect. 1990; 80(3): 225-30.
47. Tang Y, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF. Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C - > T) with plasma dopamine beta-hydroxylase activity. Am J Med Genet B Neuropsychiatr Genet. 2005; 139(1): 88-90.
48. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry. 1998; 39(1): 65-99.
49. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet. 1998; 63(6): 1767-76.
50. Wei J, Ramchand CN, Hemmings GP. Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet. 1997; 99(1): 52-5.
51. Weinshilboum RM. Serum dopamine beta-hydroxylase. Pharmacol Rev. 1978; 30(2): 133-66.
52. Weinshilboum R, Axelrod J. Serum dopamine- -hydroxylase: decrease after chemical sympathectomy. Science. 1971; 173(4000): 931-4.
53. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH. Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. Science. 1973; 181(103): 943-5.
54. Wigg K, Zai G, Schachar R, Tannock R, Roberts W, Malone M, et al. Attention deficit hyperactivity disorder and the gene for dopamine Beta-hydroxylase. Am J Psychiatry. 2002; 159(6): 1046-8.
55. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet. 2001; 68(2): 515-22.
56. Zabetian CP, Buxbaum SG, Elston RC, Kohnke MD, Anderson GM, Gelernter J, et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet. 2003; 72(6): 1389-400.
57. Zhang HB, Wang YF, Li J, Wang B, Yang L. [Association of dopamine beta-hydroxylase polymorphism with attention deficit hyperactivity disorder in children] [Article in Chinese] Beijing Da Xue Xue Bao. 2004; 36(3): 290-3.
58. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976; 261(5558): 333-5.